Phase 1/2 Trial of mTAA T Cells in Advanced Pancreatic Cancer: Safety & Early Efficacy
The Future of Cancer Treatment: Personalized T-Cell Therapies Take Center Stage A groundbreaking clinical trial, TACTOPS, recently published details on a novel approach to fighting pancreatic cancer using autologous mTAA T-cells. While still early days, the meticulous methodology – approved by leading institutions like Baylor College of Medicine and Houston Methodist Hospital, and overseen by … Read more